Self-sampling for human papillomavirus testing among non-attenders increases attendance to the norwegian cervical cancer screening programme

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Enerly, Espen ^a   Bonde, Jesper ^b   Schee, Kristina ^a   Pedersen, Helle ^b   Lönnberg, Stefan ^a   Nygård, Mari ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CERVICOVAGINAL SELF-SAMPLING DEVICE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; FEMALE; FOLLOW UP; GYNECOLOGICAL AND OBSTETRIC SAMPLING DEVICE; HEALTH PROGRAM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; NONHUMAN; NORWAY; NORWEGIAN CERVICAL CANCER SCREENING PROGRAM; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS EXAMINATION; WART VIRUS; CLINICAL TRIAL; DEVICES; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; PAPILLOMAVIRIDAE; PROCEDURES; PUBLIC HEALTH; SELF CARE; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NORWAY; PAPILLOMAVIRIDAE; SELF CARE; UTERINE CERVICAL NEOPLASMS;

EID: 84963865184     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151978     Document Type: Article

References (28)

1. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A (2009) Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 45: 2640-2648. doi: 10.1016/j.ejca.2009.07.018 PMID: 19695864
2. Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, et al. (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomised controlled trials. Lancet 383: 524-532. doi: 10.1016/S0140-6736(13)62218-7 PMID: 24192252
3. Andreassen T, Vogt C (2014) Screening for cervical cancer-future perspectives. Tidsskr Nor Laegeforen 134: 1122-1123. doi: 10.4045/tidsskr.14.0240 PMID: 24939773
4. Sasieni P, Castanon A, Cuzick J (2009) Effectiveness of cervical screening with age: Population based case-control study of prospectively recorded data. BMJ 339: B2968. doi: 10.1136/bmj.b2968 PMID: 19638651
5. Andrae B, Kemetli L, Sparen P, Silfverdal L, Strander B, Ryd W, et al. (2008) Screening-preventable cervical cancer risks: Evidence from a nationwide audit in Sweden. J Natl Cancer Inst 100: 622-629. doi: 10.1093/jnci/djn099 PMID: 18445828
6. Lonnberg S, Nieminen P, Luostarinen T, Anttila A (2013) Mortality audit of the Finnish cervical cancer screening program. Int J Cancer 132: 2134-2140. doi: 10.1002/ijc.27844 PMID: 22987437
7. Nygard JF, Nygard M, Skare GB, Thoresen SO (2005) Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: A retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program. Cancer Causes Control 16: 463-474. PMID: 15953989
8. Bosgraaf RP, Ketelaars PJ, Verhoef VM, Massuger LF, Meijer CJ, Melchers WJ, et al. (2014) Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prev Med 64C: 108-113.
9. Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, et al. (2011) The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: A randomised controlled trial (ISRCTN96071600). Br J Cancer 104: 248-254. doi: 10.1038/sj.bjc.6606040 PMID: 21179038
10. Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, et al. (2011) HPV self-sampling as an alternative strategy in non-attenders for cervical screening-a randomised controlled trial. Br J Cancer 104: 915-920. doi: 10.1038/bjc.2011.48 PMID: 21343937
11. Eaker S, Adami HO, Sparen P (2001) Reasons women do not attend screening for cervical cancer: A population-based study in Sweden. Prev Med 32: 482-491. PMID: 11394952
12. Hansen BT, Hukkelberg SS, Haldorsen T, Eriksen T, Skare GB, Nygard M (2011) Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: A cross-sectional study of 12,058 Norwegian women. BMC Public Health 11: 264. doi: 10.1186/1471-2458-11-264 PMID: 21521515
13. Racey CS, Withrow DR, Gesink D (2013) Self-collected HPV Testing Improves Participation in Cervical Cancer Screening: A Systematic Review and Meta-analysis. Can J Public Health 104: E159-166. PMID: 23618210
14. Cancer Registry of Norway. Cancer in Norway 2010-Cancer incidence, mortality, survival and prevalence in Norway. Oslo, Norway. Cancer Registry of Norway; 2012.
15. Nygard JF, Skare GB, Thoresen SO (2002) The cervical cancer screening programme in Norway, 1992-2000: Changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 9: 86-91. PMID: 12133929
16. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs, Volume 100 (B) ed. Lyon, France. International Agency for Research on Cancer; 2012.
17. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174. PMID: 843571
18. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. (2014) Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: A meta-analysis. Lancet Oncol 15: 172-183. doi: 10.1016/S1470-2045(13)70570-9 PMID: 24433684
19. Lönnberg S, Skare GB (2014) Masseundersøkelsen mot livmorhalskreft: Årsrapport 2012 (English: Norwegian Cervical Cancer Screening Program: 2012 report). Cancer Registry of Norway.
20. Rebolj M, Pribac I, Frederiksen ME, Lynge E (2013) The problem of false-positive human papillomavirus DNA tests in cervical screening. Curr Pharm Des 19: 1439-1449. PMID: 23016777
21. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, De Sanjose S (2010) Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202: 1789-1799. doi: 10.1086/657321 PMID: 21067372
22. Rebolj M, Preisler S, Ejegod DM, Rygaard C, Lynge E, Bonde J (2014) Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening. PLoS One 9: E86835. doi: 10.1371/journal.pone.0086835 PMID: 24466262
23. Castle PE, Solomon D, Wheeler CM, Gravitt PE, Wacholder S, Schiffman M (2008) Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 46: 2595-2604. doi: 10.1128/JCM. 00824-08 PMID: 18579716
24. Poljak M, Kocjan BJ, Kovanda A, Lunar MM, Lepej SZ, Planinic A, et al. (2009) Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail. J Clin Microbiol 47: 2611-2615. doi: 10. 1128/JCM.00278-09 PMID: 19494080
25. Arbyn M, Tommasino M, Depuydt C, Dillner J (2014) Are 20 human papillomavirus types causing cervical cancer? J Pathol 234: 431-435. doi: 10.1002/path.4424 PMID: 25124771
26. Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJF, Arbyn M (2015) Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials. European Journal of Cancer 51: 2375-2385. doi: 10.1016/j.ejca.2015.07.006 PMID: 26296294
27. Giorgi Rossi P, Fortunato C, Barbarino P, Boveri S, Caroli S, Del Mistro A, et al. (2015) Self-sampling to increase participation in cervical cancer screening: An RCT comparing home mailing, distribution in pharmacies, and recall letter. Br J Cancer 112: 667-675. doi: 10.1038/bjc.2015.11 PMID: 25633037
28. Broberg G, Gyrd-Hansen D, Miao Jonasson J, Ryd M-L, Holtenman M, Milsom I, et al. (2014) Increasing participation in cervical cancer screening: OFFERING a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. International Journal of Cancer 134: 2223-2230. doi: 10.1002/ijc.28545 PMID: 24127304